1. All Products
  2. EPINEPHRINE (adrenaline) tartrate, eq.1mg/ml base,1ml amp IM
Public Pricelist

EPINEPHRINE (adrenaline) tartrate, eq.1mg/ml base,1ml amp IM

https://medicalguidelines.msf.org/en/node/797
https://unicat.msf.org/cat/product/11676
STD DINJEPIN1AM

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
12.2 - Antiarrhythmic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
25.1 - Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
3 - Antiallergics and medicines used in anaphylaxis
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C01CA24
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

EPINEPHRINE (adrenaline)

Full Name

Synonym: Levorenin

Therapeutic Action

Sympathomimetic

Indications

Cardiac arrest

Severe anaphylaxis

Life threatening hypotension

Adjuvant treatment of shock that persists despite adequate intravascular filling

Inotropic support

Instructions for use

Two presentations for different indications (IM or IV route):

  • IM route: no dilution required (1:1000 solution)
  • IV route: dilute 1 ampoule in 9 ml of 0.9% NaCl to obtain a solution containing 0.1 mg/ml epinephrine (1:10 000 solution)

For hospital settings, order the IV presentation.

In severe acute laryngotracheobronchitis AND under the strict responsibility of the clinical practitioner, epinephrine may be given by nebulisation (using 1 mg/ml ampoule) in 5 ml of 0.9% NaCl, in combination with IM dexamethasone.

Precautions for Use

Depending on the manufacturer, the route of administration is specified on the packaging (IM only, or IV only).

Before administration, check the concentration and route of administration indicated on the ampoule.

Discard ampoules with pink or brownish contents (epinephrine solution is colourless).

Storage

  • Below 25ºC - Protect from sunlight
  • Keep the ampoules in the protective secondary packaging.